Learn more about our work through our latest media releases and blog posts.
GPOL will provide genomic sequencing for the University of Glasgow-led PREDICT-Meso (Pre-malignant drivers combined with target-drug validation in mesothelioma), a new £5 million mesothelioma project…
A collaborative global scientific effort, which includes a group of researchers from the University of Glasgow, has completed the most comprehensive study of whole cancer…
Following the launch of the Glasgow Cancer Assays in November, John Windell from The Biomedical Scientist interviewed Dr Susie Cooke, GPOL Deputy Director and Head…
Deputy Director and Head of Medical Genomics, Dr Susie Cooke will be speaking at the Festival of Genomics & Biodata in London on 29 January…
The Glasgow Precision Oncology Laboratory is delighted to announce that a network of Italian cancer centres will be evaluating the Glasgow Cancer Test over the…
Wolfson Wohl Cancer Research Centre 5th anniversary- Thank you to donors
GPOL at the University of Glasgow has developed the groundbreaking new Glasgow Cancer Assays – a suite of affordable, fit-for-purpose, solid and haematological cancer genomic…
Prof Biankin was awarded Officer (AO) of the Order of Australia for distinguished service to medical research, and to the treatment of pancreatic cancer, as…
Prof Biankin and Dr Cooke discuss the genomic test that could link patients to better treatments.
GPOL was delighted to see Prof Andrew Biankin and team recognised for their work in pancreatic cancer.
